Chromik, Jörg

Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study

Platzbecker, U., Germing, U., Götze, K. S., Kiewe, P., Mayer, K., Chromik, J., Radsak, M., Wolff, T., Zhang, X., Laadem, A., et al. (2017) · The Lancet Oncology

Acute Myeloid Leukemia ResearchErythropoietin and Anemia Treatment

Cited by 292

Siremadlin (HDM201) Is Well Tolerated and Demonstrates Clinical Activity in Patients with Acute Myeloid Leukemia Who Have Relapsed after Allogeneic Stem Cell Transplantation: A Subset Analysis of Safety and Preliminary Efficacy

Stein, E. M., Chromik, J., Carpio, C., Mous, R., Kiladjian, J.-J., Alatrash, G., Curti, A., Craddock, C., Schmid, C., Zeiser, R., et al. (2021) · Blood

Acute Myeloid Leukemia ResearchCancer-related Molecular Pathways

Cited by 8